早期诊断NEC无创性生物标志物的研究进展
Advances in Non-Invasive Biomarkers for Early Diagnosis of NEC
DOI: 10.12677/acm.2024.143875, PDF,   
作者: 王静文, 李禄全*:重庆医科大学附属儿童医院新生儿诊疗中心,国家儿童健康与疾病临床医学研究中心,儿童发育疾病研究教育部重点实验室,儿童神经发育与认知障碍重庆市重点实验室,重庆
关键词: 新生儿坏死性小肠结肠炎早期诊断无创性生物标志物Neonatal Necrotizing Enterocolitis Early Diagnosis Non-Invasive Biomarker
摘要: 坏死性小肠结肠炎(necrotizing enterocolitis, NEC)是新生儿常见的消化系统疾病,尤其多见于早产儿和低出生体重儿。NEC起病隐匿,进展快,可迅速发展为爆发性NEC,其死亡率高达50%,且存活患儿容易出现各种与之相关的严重后遗症,严重影响患儿的生存质量。因此,早期诊断NEC显得尤为必要。本文就目前关于无创性生物标志物在NEC早期诊断中的研究进展作一综述。
Abstract: Necrotizing enterocolitis (NEC) is a common digestive disease in newborns, especially in premature and low birth weight infants. NEC has a hidden onset, rapid progression, and can rapidly develop into explosive NEC, with a mortality rate of up to 50%. Surviving children are prone to a variety of related serious sequelae, seriously affecting their quality of life. Therefore, early diagnosis of NEC is particularly necessary. This article reviews the progress of non-invasive biomarkers in the early diagnosis of NEC.
文章引用:王静文, 李禄全. 早期诊断NEC无创性生物标志物的研究进展[J]. 临床医学进展, 2024, 14(3): 1529-1535. https://doi.org/10.12677/acm.2024.143875

参考文献

[1] Kaplina, A., Kononova, S., Zaikova, E., et al. (2023) Necrotizing Enterocolitis: The Role of Hypoxia, Gut Microbiome, and Microbial Metabolites. International Journal of Molecular Sciences, 24, Article 2471. [Google Scholar] [CrossRef] [PubMed]
[2] Aladangady, N. and Sanderson, I. (2023) Editorial: Biomarkers of Gut Blood Flow, Oxygenation, Inflammation and NEC in Neonates. Frontiers in Pediatrics, 11, Article 1234832. [Google Scholar] [CrossRef] [PubMed]
[3] Meister, A.L., Doheny, K.K. and Travagli, R.A. (2020) Necrotizing Enterocolitis: It’s Not All in the Gut. Experimental Biology and Medicine, 245, 85-95. [Google Scholar] [CrossRef] [PubMed]
[4] Bethell, G.S. and Hall, N.J. (2023) Recent Advances in Our Understanding of NEC Diagnosis, Prognosis and Surgical Approach. Frontiers in Pediatrics, 11, Article 1229850. [Google Scholar] [CrossRef] [PubMed]
[5] Bell, M.J., Ternberg, J.L., Feigin, R.D., et al. (1978) Neonatal Necrotizing Enterocolitis. Therapeutic Decisions Based upon Clinical Staging. Annals of Surgery, 187, 1-7. [Google Scholar] [CrossRef] [PubMed]
[6] Asiri, A.S., Algarni, S.S., Althubaiti, A.Q., et al. (2023) Fecal Calprotectin and Organic Gastrointestinal Disease: A Systematic Review. Cureus, 15, e45019. [Google Scholar] [CrossRef] [PubMed]
[7] Qu, Y., Xu, W., Han, J., et al. (2020) Diagnostic Value of Fecal Calprotectin in Necrotizing Enterocolitis: A Meta-Analysis. Early Human Development, 151, Article ID: 105170. [Google Scholar] [CrossRef] [PubMed]
[8] MacQueen, B.C., Christensen, R.D., Yost, C.C., et al. (2016) Elevated Fecal Calprotectin Levels during Necrotizing Enterocolitis Are Associated with Activated Neutrophils Extruding Neutrophil Extracellular Traps. Journal of Perinatology, 36, 862-869. [Google Scholar] [CrossRef] [PubMed]
[9] Pergialiotis, V., Konstantopoulos, P., Karampetsou, N., et al. (2016) Calprotectin Levels in Necrotizing Enterocolitis: A Systematic Review of the Literature. Inflammation Research, 65, 847-852. [Google Scholar] [CrossRef] [PubMed]
[10] Van Zoonen, A.G.J.F., Hulzebos, C.V., Muller Kobold, A.C., et al. (2019) Serial Fecal Calprotectin in the Prediction of Necrotizing Enterocolitis in Preterm Neonates. Journal of Pediatric Surgery, 54, 455-459. [Google Scholar] [CrossRef] [PubMed]
[11] Goold, E., Pearson, L. and Johnson, L.M. (2020) Can Fecal Calprotectin Serve as a Screen for Necrotizing Enterocolitis in Infants? Clinical Biochemistry, 84, 51-54. [Google Scholar] [CrossRef] [PubMed]
[12] Hong, L., Huang, Y., Jiang, S., et al. (2023) Postnatal Dynamics and Clinical Associations of Fecal Calprotectin in Very Preterm Infants: Implications for Necrotizing Enterocolitis and Feeding Intolerance. Clinical and Translational Gastroenterology, 14, e00604. [Google Scholar] [CrossRef] [PubMed]
[13] Agakidou, E., Agakidis, C., Gika, H. and Sarafidis, K. (2020) Emerging Biomarkers for Prediction and Early Diagnosis of Necrotizing Enterocolitis in the Era of Metabolomics and Proteomics. Frontiers in Pediatrics, 8, Article 602255. [Google Scholar] [CrossRef] [PubMed]
[14] Coufal, S., Kokesova, A., Tlaskalova-Hogenova, H., et al. (2020) Urinary I-FABP, L-FABP, TFF-3, and SAA Can Diagnose and Predict the Disease Course in Necrotizing Enterocolitis at the Early Stage of Disease. Journal of Immunology Research, 2020, Article ID: 3074313. [Google Scholar] [CrossRef] [PubMed]
[15] El-Abd Ahmed, A., Hassan, M.H., Abo-Halawa, N., et al. (2020) Lactate and Intestinal Fatty Acid Binding Protein as Essential Biomarkers in Neonates with Necrotizing Enterocolitis: Ultrasonographic and Surgical Considerations. Pediatrics & Neonatology, 61, 481-489. [Google Scholar] [CrossRef] [PubMed]
[16] Gregory, K.E., Winston, A.B., Yamamoto, H.S., et al. (2014) Urinary Intestinal Fatty Acid Binding Protein Predicts Necrotizing Enterocolitis. The Journal of Pediatrics, 164, 1486-1488. [Google Scholar] [CrossRef] [PubMed]
[17] Ho, S.S.C., Keenan, J.I. and Day, A.S. (2020) The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases. Digestive Diseases and Sciences, 65, 376-390. [Google Scholar] [CrossRef] [PubMed]
[18] Saran, A., Devegowda, D. and Doreswamy, S.M. (2020) Urinary Intestinal Fatty Acid Binding Protein for Diagnosis of Necrotizing Enterocolitis. Indian Pediatrics, 57, 798-800. [Google Scholar] [CrossRef
[19] Liu, J., Yang, Q., Chen, Z., et al. (2021) TFF3 Mediates the NF-κB/COX2 Pathway to Regulate PMN-MDSCs Activation and Protect against Necrotizing Enterocolitis. European Journal of Immunology, 51, 1110-1125. [Google Scholar] [CrossRef] [PubMed]
[20] Liu, J., Li, Y., Feng, Y., et al. (2019) Patterned Progression of Gut Microbiota Associated with Necrotizing Enterocolitis and Late Onset Sepsis in Preterm Infants: A Prospective Study in a Chinese Neonatal Intensive Care Unit. PeerJ, 7, e7310. [Google Scholar] [CrossRef] [PubMed]
[21] Goldstein, G.P. and Sylvester, K.G. (2019) Biomarker Discovery and Utility in Necrotizing Enterocolitis. Clinics in Perinatology, 46, 1-17. [Google Scholar] [CrossRef] [PubMed]
[22] Blackwood, B.P., Wood, D.R., Yuan, C.Y., Nicolas, J.D., Griffiths, A., Mestan, K. and Hunter, C.J. (2015) Urinary Claudin-2 Measurements as a Predictor of Necrotizing Enterocolitis: A Pilot Study. Journal of Neonatal Surgery, 4, 43. [Google Scholar] [CrossRef
[23] Thuijls, G., Derikx, J.P., Van Wijck, K., et al. (2010) Non-Invasive Markers for Early Diagnosis and Determination of the Severity of Necrotizing Enterocolitis. Annals of Surgery, 251, 1174-1180. [Google Scholar] [CrossRef
[24] Chen, R., Chen, Q., Zheng, J., et al. (2023) Serum Amyloid Protein A in Inflammatory Bowel Disease: From Bench to Bedside. Cell Death Discovery, 9, Article No. 154. [Google Scholar] [CrossRef] [PubMed]
[25] Reisinger, K.W., Van Der Zee, D.C., Brouwers, H.A., et al. (2012) Noninvasive Measurement of Fecal Calprotectin and Serum Amyloid a Combined with Intestinal Fatty Acid-Binding Protein in Necrotizing Enterocolitis. Journal of Pediatric Surgery, 47, 1640-1645. [Google Scholar] [CrossRef] [PubMed]
[26] Reisinger, K.W., Kramer, B.W., Van Der Zee, D.C., et al. (2014) Non-Invasive Serum Amyloid A (SAA) Measurement and Plasma Platelets for Accurate Prediction of Surgical Intervention in Severe Necrotizing Enterocolitis (NEC). PLOS ONE, 9, e90834. [Google Scholar] [CrossRef] [PubMed]
[27] Duchon, J., Barbian, M.E. and Denning, P.W. (2021) Necrotizing Enterocolitis. Clinics in Perinatology, 48, 229-250. [Google Scholar] [CrossRef] [PubMed]
[28] Tarracchini, C., Milani, C., Longhi, G., et al. (2021) Unraveling the Microbiome of Necrotizing Enterocolitis: Insights in Novel Microbial and Metabolomic Biomarkers. Microbiology Spectrum, 9, e0117621. [Google Scholar] [CrossRef
[29] Feng, J., He, Y., Liu, D., et al. (2019) The Constitution and Functional Prediction of the Microbiota in Necrotizing Enterocolitis with a Gestational Age of over 28 Weeks. Medicine, 98, e17206. [Google Scholar] [CrossRef
[30] Saturio, S., Nogacka, A.M., Suárez, M., et al. (2021) Early-Life Development of the Bifidobacterial Community in the Infant Gut. International Journal of Molecular Sciences, 22, Article 3382. [Google Scholar] [CrossRef] [PubMed]
[31] Du, T.T., Liu, X.C., He, Y., et al. (2023) Changes of Gut Microbiota and Tricarboxylic Acid Metabolites May Be Helpful in Early Diagnosis of Necrotizing Enterocolitis: A Pilot Study. Frontiers in Microbiology, 14, Article 1119981. [Google Scholar] [CrossRef] [PubMed]
[32] Hosfield, B.D., Drucker, N.A., Pecoraro, A.R., et al. (2021) The Assessment of Microbiome Changes and Fecal Volatile Organic Compounds during Experimental Necrotizing Enterocolitis. Journal of Pediatric Surgery, 56, 1220-1225. [Google Scholar] [CrossRef] [PubMed]
[33] Masi, A.C., Embleton, N.D., Lamb, C.A., et al. (2021) Human Milk Oligosaccharide DSLNT and Gut Microbiome in Preterm Infants Predicts Necrotising Enterocolitis. Gut, 70, 2273-2282. [Google Scholar] [CrossRef] [PubMed]
[34] Neu, J. (2020) Necrotizing Enterocolitis: A Multi-Omic Approach and the Role of the Microbiome. Digestive Diseases and Sciences, 65, 789-796. [Google Scholar] [CrossRef] [PubMed]
[35] Pammi, M., Cope, J., Tarr, P.I., et al. (2017) Intestinal Dysbiosis in Preterm Infants Preceding Necrotizing Enterocolitis: A Systematic Review and Meta-Analysis. Microbiome, 5, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
[36] Berkhout, D.J.C., Niemarkt, H.J., De Boer, N.K.H., et al. (2018) The Potential of Gut Microbiota and Fecal Volatile Organic Compounds Analysis as Early Diagnostic Biomarker for Necrotizing Enterocolitis and Sepsis in Preterm Infants. Expert Review of Gastroenterology & Hepatology, 12, 457-470. [Google Scholar] [CrossRef] [PubMed]
[37] Garner, C.E., Ewer, A.K., Elasouad, K., et al. (2009) Analysis of Faecal Volatile Organic Compounds in Preterm Infants Who Develop Necrotising Enterocolitis: A Pilot Study. Journal of Pediatric Gastroenterology and Nutrition, 49, 559-565. [Google Scholar] [CrossRef
[38] De Meij, T.G., Van Der Schee, M.P., Berkhout, D.J., et al. (2015) Early Detection of Necrotizing Enterocolitis by Fecal Volatile Organic Compounds Analysis. The Journal of Pediatrics, 167, 562-567.E1. [Google Scholar] [CrossRef] [PubMed]
[39] Probert, C., Greenwood, R., Mayor, A., et al. (2020) Faecal Volatile Organic Compounds in Preterm Babies at Risk of Necrotising Enterocolitis: The DOVE Study. ADC Fetal & Neonatal Edition, 105, 474-479. [Google Scholar] [CrossRef] [PubMed]
[40] Hosfield, B.D., Pecoraro, A.R., Baxter, N.T., et al. (2020) The Assessment of Fecal Volatile Organic Compounds in Healthy Infants: Electronic Nose Device Predicts Patient Demographics and Microbial Enterotype. Journal of Surgical Research, 254, 340-347. [Google Scholar] [CrossRef] [PubMed]
[41] Martins, R.D.S., Kooi, E.M.W., Poelstra, K., et al. (2023) The Role of Intestinal Alkaline Phosphatase in the Development of Necrotizing Enterocolitis. Early Human Development, 183, Article ID: 105797. [Google Scholar] [CrossRef] [PubMed]
[42] Kampanatkosol, R., Thomson, T., Habeeb, O., et al. (2014) The Relationship between Reticulated Platelets, Intestinal Alkaline Phosphatase, and Necrotizing Enterocolitis. Journal of Pediatric Surgery, 49, 273-276. [Google Scholar] [CrossRef] [PubMed]
[43] Heath, M., Buckley, R., Gerber, Z., et al. (2019) Association of Intestinal Alkaline Phosphatase with Necrotizing Enterocolitis Among Premature Infants. JAMA Network Open, 2, e1914996. [Google Scholar] [CrossRef] [PubMed]
[44] Sugino, H. and Sawada, Y. (2022) Influence of S100A2 in Human Diseases. Diagnostics, 12, Article 1756. [Google Scholar] [CrossRef] [PubMed]
[45] Däbritz, J., Jenke, A., Wirth, S. and Foell, D. (2012) Fecal Phagocyte-Specific S100A12 for Diagnosing Necrotizing Enterocolitis. The Journal of Pediatrics, 161, 1059-1064. [Google Scholar] [CrossRef] [PubMed]
[46] Pham, T., Lau, Z.J., Chen, S.H.A., et al. (2021) Heart Rate Variability in Psychology: A Review of HRV Indices and an Analysis Tutorial. Sensors, 21, Article 3998. [Google Scholar] [CrossRef] [PubMed]
[47] Al-Shargabi, T., Reich, D., Govindan, R.B., et al. (2018) Changes in Autonomic Tone in Premature Infants Developing Necrotizing Enterocolitis. American Journal of Perinatology, 35, 1079-1086. [Google Scholar] [CrossRef] [PubMed]
[48] Meister, A.L., Gardner, F.C., Browning, K.N., et al. (2021) Vagal Tone and Proinflammatory Cytokines Predict Feeding Intolerance and Necrotizing Enterocolitis Risk. Advances in Neonatal Care, 21, 452-461. [Google Scholar] [CrossRef
[49] Meister, A.L., Doheny, K.K. and Travagli, R.A. (2019) Necrotizing Enterocolitis Attenuates Developmental Heart Rate Variability Increases in Newborn Rats. Neurogastroenterology & Motility, 31, e13484. [Google Scholar] [CrossRef] [PubMed]
[50] Rusconi, B., Jiang, X., Sidhu, R., et al. (2018) Gut Sphingolipid Composition as a Prelude to Necrotizing Enterocolitis. Scientific Reports, 8, Article No. 10984. [Google Scholar] [CrossRef] [PubMed]
[51] Thomaidou, A., Chatziioannou, A.C., Deda, O., et al. (2019) A Pilot Case-Control Study of Urine Metabolomics in Preterm Neonates with Necrotizing Enterocolitis. Journal of Chromatography B, 1117, 10-21. [Google Scholar] [CrossRef] [PubMed]
[52] Thibault, M.P., Tremblay, É., Horth, C., et al. (2022) Lipocalin-2 and Calprotectin as Stool Biomarkers for Predicting Necrotizing Enterocolitis in Premature Neonates. Pediatric Research, 91, 129-136. [Google Scholar] [CrossRef] [PubMed]
[53] Konishi, K.I., Yoshida, M., Nakao, A., et al. (2019) Prostaglandin E-Major Urinary Metabolite as a Noninvasive Surrogate Marker for Infantile Necrotizing Enterocolitis. Journal of Pediatric Surgery, 54, 1584-1589. [Google Scholar] [CrossRef] [PubMed]